SI
MGNX icon

Sofinnova Investments’s MacroGenics MGNX Stock Holding History

Sofinnova Investments’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-234,504
Closed -$6.3M – 79
2021
Q2 		$6.3M Buy
234,504
+161,303
+220% +$4.72M 0.36% 43
2021
Q1 		$2.33M Sell
73,201
-385,606
-84% -$9.36M 0.14% 61
2020
Q4 		$10.5M Buy
+458,807
New +$10.6M 0.62% 32
2020
Q1 		– Sell
-1,173,882
Closed -$12.8M – 67
2019
Q4 		$12.8M Buy
1,173,882
+592,328
+102% +$5.86M 0.92% 24
2019
Q3 		$7.42M Buy
581,554
+31,111
+6% +$448K 0.67% 33
2019
Q2 		$9.34M Buy
550,443
+26,687
+5% +$458K 0.86% 27
2019
Q1 		$9.42M Buy
523,756
+190,835
+57% +$3.3M 0.91% 24
2018
Q4 		$4.23M Buy
+332,921
New +$5.58M 0.53% 36

Other funds holding MGNX

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sofinnova Investments's MGNX Position: Q3 2021 in Review

Sofinnova Investments sold out of MacroGenics (MGNX) in Q3 2021, closing a stake of 234,504 shares — an estimated $6.3M sold.

Sofinnova Investments first reported a position in MGNX in Q4 2018 and held it in 8 quarters. The position peaked at $12.8M in Q4 2019. 154 funds tracked by Wall St. Rank hold MGNX as of Q3 2021.

  • Sofinnova Investments reported no remaining MacroGenics position as of Q3 2021 after selling out during the quarter.
  • Sofinnova Investments sold 234,504 MacroGenics shares in Q3 2021, an estimated $6.3M.
  • Sofinnova Investments first reported a position in MacroGenics in Q4 2018 and held it in 8 quarters.
  • Sofinnova Investments's MacroGenics position peaked at $12.8M in Q4 2019.
  • 154 funds tracked by Wall St. Rank held MacroGenics as of Q3 2021.

Based on Sofinnova Investments's 13F filing for Q3 2021, filed 15 Nov 2021.